Breaking

fda

FDA funds study on LLMs evaluating AI radiology reports
Personal Health

FDA funds study on LLMs evaluating AI radiology reports

The FDA awarded Cognita Imaging $1.29M to test if large language models can evaluate AI radiology reports, addressing a key gap in…

Seraphina Wentworth · September 21, 2026
Robotic surgery system gains CE mark for vaginal procedures
Gut Health

Robotic surgery system gains CE mark for vaginal procedures

Intuitive Surgical’s da Vinci SP robotic system earns CE mark for vaginal procedures, expanding minimally invasive gynecologic surgery options in Europe.

Ottoline Dunmore · September 16, 2026
Medicare now covers TAVR for some asymptomatic heart patients
Gut Health

Medicare now covers TAVR for some asymptomatic heart patients

Medicare now covers TAVR for asymptomatic patients with severe aortic stenosis, expanding access to life-saving valve replacement without symptoms.

Ottoline Dunmore · September 15, 2026
FDA tightens human factors rules for medical devices
Gut Health

FDA tightens human factors rules for medical devices

The FDA’s stricter human factors rules for medical devices now prioritize usability engineering as a core safety requirement, reshaping validation standards for

Ottoline Dunmore · September 14, 2026
FDA’s generative AI strategy faces four key questions
Mind Body

FDA’s generative AI strategy faces four key questions

Generative AI regulation takes center stage as the FDA unveils its strategy, tackling approval pathways, safety standards, industry uncertainty, and oversight.

Ottoline Dunmore · September 10, 2026
FDA approves Rusfertide for erythrocytosis in polycythemia vera
Gut Health

FDA approves Rusfertide for erythrocytosis in polycythemia vera

FDA approves rusfertide (Mimrylo) for erythrocytosis, sparing polycythemia vera patients from painful phlebotomies. Read the latest medical news.

Persephone Blackwood · August 30, 2026
FDA Approves New Narcolepsy Treatment
Gut Health

FDA Approves New Narcolepsy Treatment

FDA approves new narcolepsy treatment targeting orexin deficiency for narcolepsy type 1 patients.

Seraphina Wentworth · August 24, 2026